APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Rotavirus Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Human Rotavirus Vaccine Industry Growth and Trends Forecast to 2032

20 December 202574 pages

Choose your research edition.

Industry ResearchHuman Rotavirus Vaccine Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Rotavirus Vaccine Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Human Rotavirus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Rotavirus Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Rotavirus Vaccine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Human Rotavirus Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Human Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Human Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Rotavirus Vaccine include Bharat Biotech, GlaxoSmithKline and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Human Rotavirus Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Rotavirus Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Rotavirus Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Rotavirus Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Human Rotavirus Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Rotavirus Vaccine Market by Company

Bharat Biotech

GlaxoSmithKline

Merck

Human Rotavirus Vaccine Segment by Type

Rotarix

RotaTeq

Lanzhou lamb

Rotavin-M1

Rotavac

Others

Human Rotavirus Vaccine Segment by Application

Hospitals & Clinics

Academic And Research

Others

Human Rotavirus Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Rotavirus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Rotavirus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Rotavirus Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Rotavirus Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Human Rotavirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Rotarix Table 2. Major Company of RotaTeq Table 3. Major Company of Lanzhou lamb Table 4. Major Company of Rotavin-M1 Table 5. Major Company of Rotavac Table 6. Major Company of Others Table 7. Global Human Rotavirus Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Human Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 9. Global Human Rotavirus Vaccine Sales Market Share in Volume by Type (2021-2026) Table 10. Global Human Rotavirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 11. Global Human Rotavirus Vaccine Sales Market Share in Value by Type (2021-2026) Table 12. Global Human Rotavirus Vaccine Price by Type (2021-2026) & (US$/Unit) Table 13. Global Human Rotavirus Vaccine Sales by Type (2027-2032) & (K Units) Table 14. Global Human Rotavirus Vaccine Sales Market Share in Volume by Type (2027-2032) Table 15. Global Human Rotavirus Vaccine Sales by Type (2027-2032) & (US$ Million) Table 16. Global Human Rotavirus Vaccine Sales Market Share in Value by Type (2027-2032) Table 17. Global Human Rotavirus Vaccine Price by Type (2027-2032) & (US$/Unit) Table 18. North America Human Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 19. North America Human Rotavirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Human Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Europe Human Rotavirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Human Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Asia-Pacific Human Rotavirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Human Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 25. Latin America Human Rotavirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Human Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 27. Middle East and Africa Human Rotavirus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 28. Human Rotavirus Vaccine Industry Trends Table 29. Human Rotavirus Vaccine Industry Drivers Table 30. Human Rotavirus Vaccine Industry Opportunities and Challenges Table 31. Human Rotavirus Vaccine Industry Restraints Table 32. Global Human Rotavirus Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Human Rotavirus Vaccine Revenue Market Share by Company (2021-2026) Table 34. Global Human Rotavirus Vaccine Sales by Company (2021-2026) & (K Units) Table 35. Global Human Rotavirus Vaccine Sales Share by Company (2021-2026) Table 36. Global Human Rotavirus Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Human Rotavirus Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Human Rotavirus Vaccine Major Company Production Sites and Headquarters Table 39. Global Human Rotavirus Vaccine Company, Product Type & Application Table 40. Global Human Rotavirus Vaccine Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Human Rotavirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Human Rotavirus Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Human Rotavirus Vaccine Sales by Region (2021-2026) & (K Units) Table 45. Global Human Rotavirus Vaccine Sales Market Share in Volume by Region (2021-2026) Table 46. Global Human Rotavirus Vaccine Sales by Region (2021-2026) & (US$ Million) Table 47. Global Human Rotavirus Vaccine Sales Market Share in Value by Region (2021-2026) Table 48. Global Human Rotavirus Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Human Rotavirus Vaccine Sales by Region (2027-2032) & (K Units) Table 50. Global Human Rotavirus Vaccine Sales Market Share in Volume by Region (2027-2032) Table 51. Global Human Rotavirus Vaccine Sales by Region (2027-2032) & (US$ Million) Table 52. Global Human Rotavirus Vaccine Sales Market Share in Value by Region (2027-2032) Table 53. Global Human Rotavirus Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Human Rotavirus Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Human Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 56. Global Human Rotavirus Vaccine Sales Market Share in Volume by Application (2021-2026) Table 57. Global Human Rotavirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 58. Global Human Rotavirus Vaccine Sales Market Share in Value by Application (2021-2026) Table 59. Global Human Rotavirus Vaccine Price by Application (2021-2026) & (US$/Unit) Table 60. Global Human Rotavirus Vaccine Sales by Application (2027-2032) & (K Units) Table 61. Global Human Rotavirus Vaccine Sales Market Share in Volume by Application (2027-2032) Table 62. Global Human Rotavirus Vaccine Sales by Application (2027-2032) & (US$ Million) Table 63. Global Human Rotavirus Vaccine Sales Market Share in Value by Application (2027-2032) Table 64. Global Human Rotavirus Vaccine Price by Application (2027-2032) & (US$/Unit) Table 65. North America Human Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 66. North America Human Rotavirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Human Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Europe Human Rotavirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Human Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Asia-Pacific Human Rotavirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Human Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 72. Latin America Human Rotavirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Human Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 74. Middle East and Africa Human Rotavirus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 75. Bharat Biotech Company Information Table 76. Bharat Biotech Business Overview Table 77. Bharat Biotech Human Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Bharat Biotech Human Rotavirus Vaccine Product Portfolio Table 79. Bharat Biotech Recent Development Table 80. GlaxoSmithKline Company Information Table 81. GlaxoSmithKline Business Overview Table 82. GlaxoSmithKline Human Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. GlaxoSmithKline Human Rotavirus Vaccine Product Portfolio Table 84. GlaxoSmithKline Recent Development Table 85. Merck Company Information Table 86. Merck Business Overview Table 87. Merck Human Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Merck Human Rotavirus Vaccine Product Portfolio Table 89. Merck Recent Development Table 90. North America Human Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 91. North America Human Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 92. North America Human Rotavirus Vaccine Sales Market Share by Country (2021-2026) Table 93. North America Human Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 94. North America Human Rotavirus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 95. North America Human Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 96. North America Human Rotavirus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 97. North America Human Rotavirus Vaccine Market Share by Country (2021-2026) Table 98. North America Human Rotavirus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 99. North America Human Rotavirus Vaccine Market Share Forecast by Country (2027-2032) Table 100. Europe Human Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 101. Europe Human Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 102. Europe Human Rotavirus Vaccine Sales Market Share by Country (2021-2026) Table 103. Europe Human Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 104. Europe Human Rotavirus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 105. Europe Human Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 106. Europe Human Rotavirus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 107. Europe Human Rotavirus Vaccine Market Share by Country (2021-2026) Table 108. Europe Human Rotavirus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 109. Europe Human Rotavirus Vaccine Market Share Forecast by Country (2027-2032) Table 110. Asia-Pacific Human Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 111. Asia-Pacific Human Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 112. Asia-Pacific Human Rotavirus Vaccine Sales Market Share by Country (2021-2026) Table 113. Asia-Pacific Human Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 114. Asia-Pacific Human Rotavirus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 115. Asia-Pacific Human Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 116. Asia-Pacific Human Rotavirus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 117. Asia-Pacific Human Rotavirus Vaccine Market Share by Country (2021-2026) Table 118. Asia-Pacific Human Rotavirus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 119. Asia-Pacific Human Rotavirus Vaccine Market Share Forecast by Country (2027-2032) Table 120. Latin America Human Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 121. Latin America Human Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 122. Latin America Human Rotavirus Vaccine Sales Market Share by Country (2021-2026) Table 123. Latin America Human Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 124. Latin America Human Rotavirus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 125. Latin America Human Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 126. Latin America Human Rotavirus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 127. Latin America Human Rotavirus Vaccine Market Share by Country (2021-2026) Table 128. Latin America Human Rotavirus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 129. Latin America Human Rotavirus Vaccine Market Share Forecast by Country (2027-2032) Table 130. Middle East and Africa Human Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 131. Middle East and Africa Human Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 132. Middle East and Africa Human Rotavirus Vaccine Sales Market Share by Country (2021-2026) Table 133. Middle East and Africa Human Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 134. Middle East and Africa Human Rotavirus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 135. Middle East and Africa Human Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 136. Middle East and Africa Human Rotavirus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 137. Middle East and Africa Human Rotavirus Vaccine Market Share by Country (2021-2026) Table 138. Middle East and Africa Human Rotavirus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 139. Middle East and Africa Human Rotavirus Vaccine Market Share Forecast by Country (2027-2032) Table 140. Key Raw Materials Table 141. Raw Materials Key Suppliers Table 142. Human Rotavirus Vaccine Distributors List Table 143. Human Rotavirus Vaccine Customers List Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Human Rotavirus Vaccine Image Figure 2. Global Human Rotavirus Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Rotavirus Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Rotavirus Vaccine Sales (2021-2032) & (K Units) Figure 5. Rotarix Image Figure 6. Global Rotarix Sales YoY Growth (2021-2032) & (K Units) Figure 7. RotaTeq Image Figure 8. Global RotaTeq Sales YoY Growth (2021-2032) & (K Units) Figure 9. Lanzhou lamb Image Figure 10. Global Lanzhou lamb Sales YoY Growth (2021-2032) & (K Units) Figure 11. Rotavin-M1 Image Figure 12. Global Rotavin-M1 Sales YoY Growth (2021-2032) & (K Units) Figure 13. Rotavac Image Figure 14. Global Rotavac Sales YoY Growth (2021-2032) & (K Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 17. Global Human Rotavirus Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Human Rotavirus Vaccine Market Share by Type 2025 VS 2032 Figure 19. North America Human Rotavirus Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. North America Human Rotavirus Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Europe Human Rotavirus Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Europe Human Rotavirus Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Human Rotavirus Vaccine Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Human Rotavirus Vaccine Sales Market Share in Value by Type in 2025 Figure 25. Latin America Human Rotavirus Vaccine Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Human Rotavirus Vaccine Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Human Rotavirus Vaccine Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Human Rotavirus Vaccine Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Human Rotavirus Vaccine Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Hospitals & Clinics Image Figure 32. Global Hospitals & Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 33. Academic And Research Image Figure 34. Global Academic And Research Sales YoY Growth (2021-2032) & (K Units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 37. Global Human Rotavirus Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Human Rotavirus Vaccine Market Share by Application 2025 VS 2032 Figure 39. North America Human Rotavirus Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. North America Human Rotavirus Vaccine Sales Market Share in Value by Application in 2025 Figure 41. Europe Human Rotavirus Vaccine Sales Market Share in Volume by Application in 2025 Figure 42. Europe Human Rotavirus Vaccine Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Human Rotavirus Vaccine Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Human Rotavirus Vaccine Sales Market Share in Value by Application in 2025 Figure 45. Latin America Human Rotavirus Vaccine Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Human Rotavirus Vaccine Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Human Rotavirus Vaccine Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Human Rotavirus Vaccine Sales Market Share in Value by Application in 2025 Figure 49. North America Human Rotavirus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. North America Human Rotavirus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Human Rotavirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Human Rotavirus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Human Rotavirus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Europe Human Rotavirus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Human Rotavirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Human Rotavirus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Human Rotavirus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Asia-Pacific Human Rotavirus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Human Rotavirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Human Rotavirus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Human Rotavirus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Latin America Human Rotavirus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Human Rotavirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Human Rotavirus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Human Rotavirus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Middle East and Africa Human Rotavirus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Human Rotavirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Human Rotavirus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Human Rotavirus Vaccine Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Human Rotavirus Vaccine Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Rotarix
  • RotaTeq
  • Lanzhou lamb
  • Rotavin-M1
  • Rotavac
  • Others
Applications
  • Hospitals & Clinics
  • Academic And Research
  • Others
Companies covered
  • Bharat Biotech
  • GlaxoSmithKline
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Rotavirus Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Human Rotavirus Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Human Rotavirus Vaccine Market by Type
  6. 1.3.1 Rotarix
  7. 1.3.2 RotaTeq
  8. 1.3.3 Lanzhou lamb
  9. 1.3.4 Rotavin-M1
  10. 1.3.5 Rotavac
  11. 1.3.6 Others
  12. 1.4 Global Human Rotavirus Vaccine Market Size by Type
  13. 1.4.1 Global Human Rotavirus Vaccine Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Human Rotavirus Vaccine Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Human Rotavirus Vaccine Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Human Rotavirus Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Human Rotavirus Vaccine Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Human Rotavirus Vaccine Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Human Rotavirus Vaccine Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Human Rotavirus Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Human Rotavirus Vaccine Industry Trends
  2. 2.2 Human Rotavirus Vaccine Industry Drivers
  3. 2.3 Human Rotavirus Vaccine Industry Opportunities and Challenges
  4. 2.4 Human Rotavirus Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Human Rotavirus Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Human Rotavirus Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Human Rotavirus Vaccine Price (2021-2026)
  4. 3.4 Global Human Rotavirus Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Rotavirus Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Human Rotavirus Vaccine Company, Product Type & Application
  7. 3.7 Global Human Rotavirus Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Rotavirus Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Rotavirus Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Rotavirus Vaccine Tier 1, Tier 2, and Tier 3
4 Human Rotavirus Vaccine Regional Status and Outlook
  1. 4.1 Global Human Rotavirus Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Human Rotavirus Vaccine Historic Market Size by Region
  3. 4.2.1 Global Human Rotavirus Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Human Rotavirus Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Human Rotavirus Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Human Rotavirus Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Human Rotavirus Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Human Rotavirus Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Human Rotavirus Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Human Rotavirus Vaccine by Application
  1. 5.1 Human Rotavirus Vaccine Market by Application
  2. 5.1.1 Hospitals & Clinics
  3. 5.1.2 Academic And Research
  4. 5.1.3 Others
  5. 5.2 Global Human Rotavirus Vaccine Market Size by Application
  6. 5.2.1 Global Human Rotavirus Vaccine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Human Rotavirus Vaccine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Human Rotavirus Vaccine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Human Rotavirus Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Human Rotavirus Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Human Rotavirus Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Human Rotavirus Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Human Rotavirus Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bharat Biotech
  2. 6.1.1 Bharat Biotech Company Information
  3. 6.1.2 Bharat Biotech Business Overview
  4. 6.1.3 Bharat Biotech Human Rotavirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bharat Biotech Human Rotavirus Vaccine Product Portfolio
  6. 6.1.5 Bharat Biotech Recent Developments
  7. 6.2 GlaxoSmithKline
  8. 6.2.1 GlaxoSmithKline Company Information
  9. 6.2.2 GlaxoSmithKline Business Overview
  10. 6.2.3 GlaxoSmithKline Human Rotavirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GlaxoSmithKline Human Rotavirus Vaccine Product Portfolio
  12. 6.2.5 GlaxoSmithKline Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Human Rotavirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Human Rotavirus Vaccine Product Portfolio
  18. 6.3.5 Merck Recent Developments
7 North America by Country
  1. 7.1 North America Human Rotavirus Vaccine Sales by Country
  2. 7.1.1 North America Human Rotavirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Human Rotavirus Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Human Rotavirus Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Human Rotavirus Vaccine Market Size by Country
  6. 7.2.1 North America Human Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Human Rotavirus Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Human Rotavirus Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Human Rotavirus Vaccine Sales by Country
  2. 8.1.1 Europe Human Rotavirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Human Rotavirus Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Human Rotavirus Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Human Rotavirus Vaccine Market Size by Country
  6. 8.2.1 Europe Human Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Human Rotavirus Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Human Rotavirus Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Human Rotavirus Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Human Rotavirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Human Rotavirus Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Human Rotavirus Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Human Rotavirus Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Human Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Human Rotavirus Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Human Rotavirus Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Human Rotavirus Vaccine Sales by Country
  2. 10.1.1 South America Human Rotavirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Human Rotavirus Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Human Rotavirus Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Human Rotavirus Vaccine Market Size by Country
  6. 10.2.1 South America Human Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Human Rotavirus Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Human Rotavirus Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Human Rotavirus Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Human Rotavirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Human Rotavirus Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Human Rotavirus Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Human Rotavirus Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Human Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Human Rotavirus Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Human Rotavirus Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Human Rotavirus Vaccine Value Chain Analysis
  2. 12.1.1 Human Rotavirus Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Human Rotavirus Vaccine Production Mode & Process
  7. 12.2 Human Rotavirus Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Human Rotavirus Vaccine Distributors
  10. 12.2.3 Human Rotavirus Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst